dc.contributor.author
Rosenthal, Annika
dc.contributor.author
Ebrahimi, Claudia
dc.contributor.author
Wedemeyer, Friederike
dc.contributor.author
Romanczuk-Seiferth, Nina
dc.contributor.author
Beck, Anne
dc.date.accessioned
2024-09-10T11:56:18Z
dc.date.available
2024-09-10T11:56:18Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/44870
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-44580
dc.description.abstract
Substance-related disorders are complex psychiatric disorders that are characterized by continued consumption in spite of harmful consequences. Addiction affects various brain networks critically involved in learning, reward, and motivation, as well as inhibitory control. Currently applied therapeutic approaches aim at modification of behavior that ultimately leads to decrease of consumption or abstinence in individuals with substance use disorders. However, traditional treatment methods might benefit from recent neurobiological and cognitive neuroscientific research findings. Novel cognitive-behavioral approaches in the treatment of addictive behavior aim at enhancement of strategies to cope with stressful conditions as well as craving-inducing cues and target erroneous learning mechanisms, including cognitive bias modification, reconsolidation-based interventions, mindfulness-based interventions, virtual-reality-based cue exposure therapy as well as pharmacological augmentation strategies. This review discusses therapeutic strategies that target dysregulated neurocognitive processes associated with the development and maintenance of disordered substance use and may hold promise as effective treatments for substance-related disorders.
en
dc.subject
Substance use disorder
en
dc.subject
Neuromodulation
en
dc.subject
Cue exposure
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
The Treatment of Substance Use Disorders: Recent Developments and New Perspectives
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1159/000525268
dcterms.bibliographicCitation.journaltitle
Neuropsychobiology
dcterms.bibliographicCitation.number
5
dcterms.bibliographicCitation.originalpublishername
Karger
dcterms.bibliographicCitation.pagestart
451
dcterms.bibliographicCitation.pageend
472
dcterms.bibliographicCitation.volume
81
dcterms.rightsHolder.note
Copyright applies in this work.
dcterms.rightsHolder.url
http://rightsstatements.org/vocab/InC/1.0/
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.note.author
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
de
refubium.note.author
This publication is shared with permission of the rights owner and made freely accessible through a DFG (German Research Foundation) funded license at either an alliance or national level.
en
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35226832
dcterms.isPartOf.issn
0302-282X
dcterms.isPartOf.eissn
1423-0224